Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Therapeutic controversy: The safety of third-generation oral contraceptives.

Therapeutic controversy: The safety of third-generation oral contraceptives. J Clin Endocrinol Metab. 1999 Jun; 84(6):1822-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.